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Corticostriatal circuits mediate various aspects of goal-directed behavior and are critically
important for basal ganglia-related disorders. Activity in these circuits is regulated by the
endocannabinoid system via stimulation of CB1 cannabinoid receptors. CB1 receptors are
highly expressed in projection neurons and select interneurons of the striatum, but expres-
sion levels vary considerably between different striatal regions (functional domains). We
investigatedCB1 receptor expressionwithin speciﬁc corticostriatal circuits bymappingCB1
mRNA levels in striatal sectors deﬁned by their cortical inputs in rats. We also assessed
changes in CB1 expression in the striatum during development. Our results show that CB1
expression is highest in juveniles (P25) and then progressively decreases toward adoles-
cent (P40) and adult (P70) levels. At every age, CB1 receptors are predominantly expressed
in sensorimotor striatal sectors, with considerably lower expression in associative and
limbic sectors. Moreover, for most corticostriatal circuits there is an inverse relationship
between cortical and striatal expression levels.Thus, striatal sectors with high CB1 expres-
sion (sensorimotor sectors) tend to receive inputs from cortical areas with low expression,
while striatal sectors with low expression (associative/limbic sectors) receive inputs from
cortical regions with higher expression (medial prefrontal cortex). In so far as CB1 mRNA
levels reﬂect receptor function, our ﬁndings suggest differential CB1 signaling between
different developmental stages and between sensorimotor and associative/limbic circuits.
The regional distribution of CB1 receptor expression in the striatum further suggests that,
in sensorimotor sectors, CB1 receptors mostly regulate GABA inputs from local axon col-
laterals of projection neurons, whereas in associative/limbic sectors, CB1 regulation of
GABA inputs from interneurons and glutamate inputs may be more important.
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INTRODUCTION
Anatomical circuits interconnecting the cerebral cortex and the
basal ganglia are critical for the organization of goal-directed
behavior, and dysfunction in these circuits is associated with
numerous brain disorders, ranging from movement disorders to
obsessive compulsive disorder, schizophrenia, and drug addiction,
depending on the particular circuits affected (e.g., Albin et al.,
1989; DeLong, 1990; Hyman and Nestler, 1996; Graybiel and
Rauch, 2000; Steiner, 2010). Cortico-basal ganglia circuits arise
from all parts of the cortex and project in a topographical man-
ner to the striatum (caudate–putamen, nucleus accumbens), and
from there, via basal ganglia output nuclei and thalamus, back to
the cortex (Alexander et al., 1986, 1990; Albin et al., 1989; Groe-
newegen et al., 1990; Joel and Weiner, 1994). Activity within these
circuits is modulated by a variety of G-protein-coupled receptors.
Among these, theGi-protein-coupledCB1 cannabinoid receptor is
of highest abundance (Herkenham et al., 1990, 1991b). CB1 recep-
tors are the main target for endocannabinoids (fatty acid signaling
molecules) and mediate the pharmacological actions of cannabi-
noid drugs (for reviews, see Kreitzer and Regehr, 2002; Freund
et al., 2003; Szabo and Schlicker, 2005; Lovinger et al., 2010). In
the basal ganglia, CB1 receptors are predominantly expressed by
striatal neurons, and are heavily localized on axon terminals within
the striatum, as well as in target nuclei of striatal projection neu-
rons, the substantia nigra and globus pallidus (Herkenham et al.,
1991a,b;Mailleux andVanderhaeghen, 1992;Matsuda et al., 1993).
Lower levels of CB1 receptors are also present throughout the cor-
tex (Herkenham et al., 1991b; Mailleux and Vanderhaeghen, 1992;
Matsuda et al., 1993; Heng et al., 2011), including in corticostriatal
neurons (Uchigashima et al., 2007).
Research over the last decade has shown that endocannabi-
noid/CB1 receptor signaling exerts powerful inhibitory effects
on both glutamatergic and GABAergic synaptic transmission in
the basal ganglia and many other brain regions. Typically, endo-
cannabinoids are formed in activated neurons, released from the
postsynaptic membrane, and diffuse to and stimulate CB1 recep-
tors onpresynaptic terminals tomodulate transmitter release (Kre-
itzer and Regehr, 2002; Freund et al., 2003; Szabo and Schlicker,
2005; Lovinger et al., 2010). Considering the prominence of CB1
receptors in cortico-basal ganglia circuits, it is not surprising that
www.frontiersin.org March 2012 | Volume 3 | Article 21 | 1
VanWaes et al. CB1 receptor expression in striatum
cannabinoids have been implicated in pathophysiology and/or
treatment of many of the disorders associated with these circuits,
includingParkinson’s andHuntington’s disease, levodopa-induced
dyskinesia, psychostimulant addiction, and schizophrenia (e.g.,
Romero et al., 2002; Brotchie, 2003; van der Stelt and Di Marzo,
2003; Wiskerke et al., 2008; Koethe et al., 2009; McCallum and
Cheer, 2009; Lovinger et al., 2010; Casadio et al., 2011). The precise
roles of CB1 receptors in these disorders remain to be determined;
however, they will depend on the particular corticostriatal circuits
involved.
The present study assessed the expression of CB1 receptors
in the various corticostriatal circuits, by mapping CB1 mRNA
throughout the striatum and associating this striatal expression
with CB1 expression in cortical input regions (Heng et al., 2011).
Our mapping approach used here was previously developed to
assign drug-induced molecular changes in the striatum to spe-
ciﬁc corticostriatal circuits (Willuhn et al., 2003; Yano and Steiner,
2005). Studies indicate that some of the effects of cannabinoid
drugs are especially critical during early brain development (see
Heng et al., 2011). We thus measured and compared CB1 expres-
sion in these circuits at three different postnatal ages, in juveniles
(postnatal day 25, P25), adolescents (P40), and adults (P70).
MATERIALS AND METHODS
SUBJECTS
CB1 mRNA expression was studied in male Sprague–Dawley rats
(Harlan, Madison, WI, USA) at P25, P40, and P70 (n = 6 each).
All procedures met the NIH guidelines for the care and use of
laboratory animals and were approved by the Rosalind Franklin
University Animal Care and Use Committee.
TISSUE PREPARATION AND IN SITU HYBRIDIZATION HISTOCHEMISTRY
The ratswere killedwithCO2,and their brainwas rapidly removed,
frozen in isopentane cooled on dry ice and then stored at −30˚C
until cryostat sectioning.Twelvemicrometer thick coronal sections
were thaw-mounted onto glass slides (Superfrost/Plus, Daigger,
Wheeling, IL, USA) and dried on a slide warmer. In prepara-
tion for the in situ hybridization histochemistry, the sections were
ﬁxed in 4% paraformaldehyde/0.9% saline for 10min at room
temperature, incubated in a fresh solution of 0.25% acetic anhy-
dride in 0.1M triethanolamine/0.9% saline (pH 8.0) for 10min,
dehydrated, defatted for 2× 5min in chloroform, rehydrated, and
air-dried. The slideswere then stored at−30˚Cuntil hybridization.
The oligonucleotide probe (48-mer; Invitrogen, Rockville,MD,
USA) was labeled with [35S]-dATP as described earlier (Willuhn
et al., 2003). The probe was complementary to bases 1051–1098 of
the CB1 mRNA (GenBank accession number X55812). One hun-
dred microliter of hybridization buffer containing labeled probe
(∼3× 106 cpm) was added to each slide. The sections were cov-
erslipped and incubated at 37˚C overnight. After incubation, the
slides were ﬁrst rinsed in four washes of 1X saline citrate (150mM
sodium chloride, 15mM sodium citrate), and then washed 3
times 20min each in 2X saline citrate/50% formamide at 40˚C,
followed by two washes of 30min each in 1X saline citrate at
room temperature. After a brief water rinse, the sections were
air-dried and then apposed to X-ray ﬁlm (BioMax MR-2, Kodak)
for 3 days.
FIGURE 1 | Regional distribution of CB1 receptor expression in the
striatum. Illustrations of ﬁlm autoradiograms show distribution of CB1
mRNA in coronal sections from the rostral, middle and caudal striatum
(outlined) in juvenile (P25) and adult (P70) rats.
ANALYSIS OF AUTORADIOGRAMS
Gene expression was assessed in sections from 3 rostrocaudal lev-
els (rostral, approximately at +1.6mm relative to bregma, Paxinos
and Watson, 1998; middle, +0.4; and caudal, −0.8; Figure 1),
in a total of 23 striatal sectors mostly deﬁned by their predom-
inant cortical inputs (Figure 2; Willuhn et al., 2003). Eighteen
of these sectors represented the caudate–putamen and ﬁve the
nucleus accumbens (Yano and Steiner, 2005). Hybridization sig-
nals onﬁlmautoradiogramsweremeasuredbydensitometry (NIH
Image; Wayne Rasband, NIMH, Bethesda, MD, USA). The ﬁlm
images were captured using a light table (Northern Light, Imaging
Research, St. Catharines, ON, Canada) and a Sony CCD camera
(Imaging Research). The“mean density”value of a region of inter-
est was measured by placing a template over the captured image.
Mean densities were corrected for background by subtracting
mean density values measured over white matter (corpus callo-
sum). Values from corresponding regions in the two hemispheres
were then averaged.
Treatment effects were determined by one- or two-factor
ANOVA, followed by Newman–Keuls post hoc tests to describe
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FIGURE 2 | Striatal sectors and their cortical inputs. Schematic illustration
depicts the 23 striatal sectors in which CB1 expression was measured. The
predominant cortical inputs to these sectors are indicated by arrows
(simpliﬁed; seeWilluhn et al., 2003). Sensorimotor, associative/limbic, and
limbic/nucleus accumbens (NAc) circuits are indicated by shading.
Abbreviations (medial–lateral): IL, infralimbic; PL, prelimbic; CG, cingulate;
M2, medial agranular; M1, motor; SS, somatosensory; I/LO, insular/lateral
orbital; I, insular.
differences between individual groups (Statistica, StatSoft, Tulsa,
OK, USA). For illustrations of topographies (maps), gene expres-
sion in a given region was expressed relative to the maximal value
(% of max.) observed in the P25 group. The illustrations of ﬁlm
autoradiograms displayed in Figure 1 are computer-generated
images, and are contrast-enhanced. Maximal hybridization signal
is black.
RESULTS
REGIONAL DISTRIBUTION OF CB1 RECEPTOR EXPRESSION IN THE
STRIATUM
CB1 receptor expression in the striatum displayed distinctive
regional variations that were very similar in the three age groups
(Figures 1, 3, and 4). CB1 mRNA levels were minimal ventrally
and medially, and highest in the dorsolateral and ventrolateral sec-
tors. Minimal CB1 mRNA expression was detected in the nucleus
accumbens at any age (Figures 1, 3, and 4). These results show
that the CB1 receptor is predominantly expressed in the sensori-
motor sectors of the striatum, with minor to minimal expression
in associative/limbic striatal regions.
DEVELOPMENTAL TRAJECTORY OF CB1 mRNA EXPRESSION
Despite the dramatic differences in expression levels between dif-
ferent striatal sectors, changes in CB1 expression across develop-
ment were, overall, similar for all sectors. CB1 mRNA levels were
maximal at P25 (Figure 1) and then decreased progressively to
P40 and to P70 (Figures 3 and 4). Levels in adult animals were
approximately 50–70% of those in juveniles. Statistical analysis
revealed that, at P70, 16 of the 18 sectors of the caudate–putamen
and one nucleus accumbens sector showed signiﬁcantly lower lev-
els, as compared to that at P25 (P < 0.05; Figures 3 and 4). From
P25 to P40, a signiﬁcant decrease was seen in 12 of the 18 caudate–
putamen sectors and 2 of the nucleus accumbens sectors (medial
and lateral core; Figure 4), and from P40 to P70, in 11 of the
caudate–putamen sectors and none of the nucleus accumbens
sectors. Exceptions to this general developmental trajectory were
found in the ventrolateral sectors on the middle and caudal levels.
These sectors displayed either no statistically signiﬁcant decrease
(middle; Figures 3 and 4), or a signiﬁcant but minor decrease
(caudal; Figure 3) in CB1 expression across development, despite
fairly high levels at P25.
CB1 mRNA EXPRESSION IN SPECIFIC CORTICOSTRIATAL CIRCUITS
To assess whether there was a relationship between cortical
and striatal CB1 expression, we compared the marked regional
variations in striatal CB1 mRNA levels shown here with vari-
ations in CB1 expression observed in the cortex (Heng et al.,
2011). An overview indicated that striatal sectors with high lev-
els of CB1 expression (e.g., sensorimotor sectors) received inputs
mostly from cortical areas with relatively low CB1 levels (motor,
somatosensory), whereas striatal sectors with low CB1 mRNA
levels (associative/limbic) received afferents from cortical areas
with higher CB1 expression (cingulate, insular). We thus assessed
whether such an inverse relationship between cortical and stri-
atal CB1 expression existed for speciﬁc corticostriatal circuits. We
compared, for all 23 corticostriatal circuits, CB1 mRNA levels in
cortical areas (Heng et al., 2011) with those in their striatal tar-
get sectors, according to the connectivity depicted in Figure 2.
For striatal sectors with more than one cortical input region
(Figure 2), the values of these cortical regions were averaged. Data
from P25, P40, and P70 animals were initially averaged for this
analysis.
Figure 5 shows the relationship between cortical and striatal
CB1 mRNA levels for the 8 sensorimotor and 15 associative/limbic
circuits (deﬁned by their striatal target sectors, Figure 2; see
Willuhn et al., 2003). For these 23 circuits pooled, there was only
a tendency for a negative correlation between cortical and striatal
CB1 expression (r =−0.35, P = 0.10). However, visual inspection
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FIGURE 3 |Topography of striatal CB1 receptor expression at different
postnatal ages and decreases in expression between juvenile and
adult rats. Maps depict the distribution of CB1 mRNA in the rostral,
middle, and caudal striatum in juveniles (P25), adolescents (P40) and adults
(P70) (left) and the differences in expression between P25 and P70 animals
(boxed; right). The data are normalized relative to the maximal value at P25
(left) or the maximal difference (right) (% of max.), and the values and
signiﬁcant decreases (P <0.05) are coded as indicated. Abbreviations:
caudate–putamen: C, central; D, dorsal; DC, dorsal central; DL, dorsolateral;
DM, dorsomedial; M, medial; V, ventral; VC, ventral central; VL,
ventrolateral; nucleus accumbens: mC, medial core; lC, lateral core; mS,
medial shell; vS, ventral shell; lS, lateral shell.
revealed three different clusters in the value distribution, indi-
cating that cohorts of circuits with different relationships existed
(Figure 5A). Further post hoc analysis showed that the eight senso-
rimotor circuits by themselves displayed a more robust tendency
for a negative correlation (r =−0.67, P = 0.07). In contrast, no
such relationship was seen when the 15 associative/limbic circuits
were considered as a group (r =−0.16). However, the scatterplot
(Figure 5A) shows that these latter circuits consisted of two clus-
ters, seven circuits involving projections from medial prefrontal
cortical areas (cingulate, prelimbic, infralimbic; Figure 2), which
have relatively high levels of CB1 expression (Heng et al., 2011),
and eight circuits with connections from lateral (insular) cortical
areas, which show relatively low CB1 expression (Figure 5A). The
seven medial prefrontal–striatal circuits indeed displayed the same
inverse relationship between cortical and striatal CB1 expression as
the sensorimotor circuits. Thus, when pooled (n = 15, Figure 5B),
these circuits showed a very robust negative correlation for cortical
and striatalCB1 expression (r =−0.92,P < 0.0001). This relation-
ship was age-independent; it was also found when the different
age groups were analyzed separately (P25, r =−0.90, P < 0.0001;
FIGURE 4 | Decrease in CB1 receptor expression during development
in select striatal sectors. Mean density values (mean±SEM) for CB1
expression at P25, P40 and P70 are given for the six sectors of the middle
striatum (top) and the ﬁve sectors of the nucleus accumbens (bottom) (for
abbreviations, see Figure 3). *P <0.05, **P <0.01, ***P <0.001, vs.
preceding age group or as indicated.
P40, r =−0.91, P < 0.0001; P70, r =−0.81, P < 0.0001). These
ﬁndings suggest that the regional expression of CB1 receptors is
related between cortical areas and their functionally associated
striatal sectors, an effect that is already present at P25 and remains
unchanged through adolescence to adulthood.
DISCUSSION
Themain ﬁndings of our present study include (1) detailed expres-
sion maps of CB1 receptors in the striatum with reference to
functional domains/corticostriatal circuits; (2) a description of
the developmental changes in striatal CB1 expression from juve-
niles to adolescents to adults; and (3) the relationship between
CB1 expression in speciﬁc striatal sectors and CB1 expression in
their cortical input regions.
ASSOCIATION OF CB1 RECEPTOR EXPRESSION WITH FUNCTIONAL
DOMAINS IN THE STRIATUM
Our present study associated striatal CB1 expression with spe-
ciﬁc functional domains/corticostriatal circuits. The functional
domains of the striatum are determined by inputs from the cor-
tex (Joel and Weiner, 1994; Parent and Hazrati, 1995). We thus
mapped the distribution of CB1 mRNA using 23 striatal sectors on
3 rostrocaudal levels thatwerepreviously designed tomostly reﬂect
cortical inputs, based on anatomical tract tracing and functional
imaging studies (see Willuhn et al., 2003; Yano and Steiner, 2005).
Functional validation and limitations of this mapping approach
have been discussed in detail elsewhere (Steiner, 2010). Given
the topographical organization of corticostriatal projections, these
sectors denote to some degree independent corticostriatal cir-
cuits; however, for descriptive purposes, these circuits are also
grouped here into the broader categories of “sensorimotor” and
“associative/limbic” (Joel and Weiner, 1994, 2000).
Our ﬁndings are overall consistent with previous work show-
ing enriched localization of CB1 mRNA in the lateral striatum in
rodents (Mailleux andVanderhaeghen, 1992; Matsuda et al., 1993;
Marsicano and Lutz, 1999; Steiner et al., 1999). Our study extends
previous ﬁndings by providing more ﬁne-grained distribution
maps. For example, our results show that CB1 expression is largely
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FIGURE 5 | Inverse relationship between cortical and striatal CB1
expression in specific corticostriatal circuits.The scatterplots (A,B) depict
CB1 expression (mean density; P25, P40, P70 averaged) in cortical areas and
their striatal target sectors for the 23 corticostriatal circuits examined. Values
for the 8 sensorimotor circuits (diamonds), 10 associative/limbic circuits
(circles), and 5 limbic/NAc circuits (squares) are displayed. Results (B) show a
negative correlation between cortical and striatal CB1 expression for pooled
sensorimotor circuits plus associative/limbic/NAc circuits with inputs from
medial prefrontal cortex (IL, PL, CG; see Figure 2) (ﬁlled symbols, n =15;
r =−0.92, ***P <0.0001). (*)P =0.07.
restricted to the sensorimotor striatum, but expression differs
between different sectors of the sensorimotor striatum. Thus,
within the sensorimotor striatum, expression is highest in the dor-
solateral and ventrolateral sectors that receive convergent inputs
from the primary motor and somatosensory cortex (e.g., McGe-
orge and Faull, 1989; Brown et al., 1998; see Willuhn et al., 2003).
CB1 expression is considerably lower in the dorsal sensorimotor
sectors which differ in that they receive dense inputs also from the
medial agranular (premotor) cortex, in addition to sensory and
motor inputs (Reep et al., 1987, 2003). The functional signiﬁcance
of this differential expression is presently unclear, but we note
that these same dorsal sectors show much more robust molecular
adaptations after treatment with psychostimulants such as cocaine
and methylphenidate than other parts of the sensorimotor stria-
tum (Willuhn et al., 2003; Yano and Steiner, 2005; Steiner, 2010).
Future studies will have to clarify the potential role of these striatal
CB1 receptors in psychostimulant-induced neuroplasticity.
In contrast to the sensorimotor striatum, CB1 mRNA levels in
associative/limbic sectors, including the nucleus accumbens, were
found to be minimal to undetectable, in agreement with previous
studies (Mailleux and Vanderhaeghen, 1992; Marsicano and Lutz,
1999; Steiner et al., 1999;Hohmann and Herkenham, 2000). These
ﬁndings suggest that CB1 effects in these regions are likely medi-
ated by CB1 receptors located on striatal afferents rather than on
intrinsic neurons (see below).
In summary, to the extent that the here observed regional varia-
tions in CB1 mRNA levels are matched by CB1 receptor function,
these ﬁndings indicate that CB1 receptors expressed by striatal
neurons predominantly regulate sensorimotor processes of the
striatum.
DEVELOPMENTAL TRAJECTORY OF CB1 mRNA EXPRESSION IN
CORTICOSTRIATAL CIRCUITS
Our developmental analysis indicates that striatal CB1 expression
is maximal in juvenile animals and then decreases toward
adulthood. This effect was largely independent of the (greatly
varying) expression levels observed in the different striatal sec-
tors. This trajectory is similar to developmental changes found
for other G-protein-coupled receptors. For example, early over-
expression followed by pruning back to adult levels has also been
shown for D1 and D2 dopamine receptors (Teicher et al., 1995;
Andersen et al., 1997; Tarazi et al., 1999), A2A adenosine recep-
tors (Johansson et al., 1997), and the putative signaling molecule
GPR88 (Van Waes et al., 2011).
A similar developmental decrease in CB1 expression from juve-
niles to adults was previously observed in cortical input regions
of the various corticostriatal circuits (Heng et al., 2011). How-
ever, in that study, we noted a differential trajectory for changes
in associative/limbic vs. sensorimotor cortical regions. Associa-
tive/limbic cortical regions showed a progressive reduction in CB1
expression from P25 to P40 to P70 (Heng et al., 2011), similar to
most striatal sectors in the present study. In contrast, decreases
in sensorimotor cortical regions mostly occurred only after the
adolescent transition period (between P40 and P70; Heng et al.,
2011), a developmental pattern of CB1 expression resembling that
observed in the ventrolateral sensorimotor sectors of the middle-
to-caudal striatum. Collectively, these ﬁndings suggest that the
maturation of CB1 expression within the associative/limbic corti-
costriatal circuits has an earlier onset than that in the sensorimotor
domain, which occurs during adolescence.
ARE CHANGES IN CB1 mRNA LEVELS REFLECTED BY CHANGES IN CB1
RECEPTOR FUNCTION?
Previous ﬁndings showed that, in the striatum, the regional dif-
ferences in CB1 receptor mRNA are matched by differences
in CB1 receptor immunoreactivity and binding (Herkenham
et al., 1991a,b; Mailleux and Vanderhaeghen, 1992; Egertová and
Elphick, 2000; Julian et al., 2003). Are these molecular varia-
tions associated with corresponding differences in CB1 receptor
function?
www.frontiersin.org March 2012 | Volume 3 | Article 21 | 5
VanWaes et al. CB1 receptor expression in striatum
Our previous study addressed the physiological signiﬁcance of
changes in CB1 mRNA levels by whole-cell patch clamp record-
ings (Heng et al., 2011). These experimentsmeasured postsynaptic
depolarization-induced suppression of excitation (DSE) in deep-
layer pyramidal neurons of the medial prefrontal cortex during
development (Heng et al., 2011). DSE is a well-established elec-
trophysiological response used to determine endocannabinoid
(CB1) regulation of synaptic activity (Kreitzer and Regehr, 2002;
Lovinger et al., 2010). Our results demonstrated thatDSE is indeed
markedly reduced in the adult prefrontal cortex as compared with
that in adolescent rats (Heng et al., 2011). These changes in DSE
thus paralleled the changes in CB1 mRNA levels. DSE was associ-
ated with a facilitation of the paired-pulse ratio (Heng et al., 2011),
indicating involvement of changes in presynaptic neurotransmit-
ter release (Thomson, 2000). Moreover, DSE was inhibited by
the CB1 receptor antagonist AM-251, conﬁrming that this effect
was mediated by activation of CB1 receptors (Heng et al., 2011).
Collectively, these electrophysiological ﬁndings indicate that this
CB1 receptor function in the cortex is down-regulated during
development, in parallel with the decrease in local CB1 receptor
expression.
Nevertheless, the relationship between CB1 mRNA and func-
tion may be different in the striatum. It will be important to
establish whether the differential CB1 mRNA levels, between dif-
ferent striatal regions and between developmental stages, are simi-
larly accompanied by differential CB1 receptor function in striatal
neurons.
CELLULAR LOCALIZATION OF CB1 RECEPTORS IN THE STRIATUM:
DIFFERENTIAL REGULATION OF GABA VS. GLUTAMATE SIGNALING IN
DIFFERENT CORTICOSTRIATAL CIRCUITS?
The distinctive differences in CB1 mRNA levels between striatal
sectors in association with those in their cortical input regions
allow for speculations regarding differential CB1 receptor signal-
ing in the different corticostriatal circuits/functional domains.
The functional signiﬁcance of these CB1 receptors is depen-
dent on their cellular localization. Striatal CB1 binding reﬂects a
combination of CB1 receptors located (1) on terminals of striatal
afferents; (2) on striatal interneurons; and (3) on striatal pro-
jection neurons. We hypothesize that CB1 receptor binding in
striatal sectors with high CB1 mRNA levels (and binding) mostly
reﬂects receptors on striatal projection neurons,more precisely, on
local axon collateral terminals of these projection neurons. This is
supported by the following ﬁndings.
CB1 receptors on afferent terminals can not account for the
distinct striatal binding patterns. For example, afferents from the
cortex, although subject to signiﬁcant presynaptic cannabinoid
regulation (e.g., Lovinger et al., 2010, for review), express relatively
low levels of CB1 receptors (e.g., Uchigashima et al., 2007; see also
discussion in Freund et al., 2003). In fact, our results indicate an
inverse relationship between cortical and striatal CB1 expression
(i.e., striatal sectors with high CB1 mRNA levels and binding tend
to receive inputs from cortical areas with low CB1 expression,
and vice versa; Figure 5). Similarly, CB1 receptors on the other
major afferents to the striatum, those from midbrain dopamine
neurons and thalamic neurons, can hardly explain the observed
patterns of striatal CB1 receptor binding, as these neurons show
minimal or no CB1 mRNA/protein expression (Herkenham et al.,
1991a; Mailleux and Vanderhaeghen, 1992; Julian et al., 2003;
Uchigashima et al., 2007). CB1 receptors are expressed at greater
levels in hippocampus and amygdala, although it remains unclear
to what extent this expression is restricted to interneurons (Freund
et al., 2003). However, inputs from these nuclei predominantly tar-
get the associative/limbic striatum (Joel and Weiner, 1994). They
may thus contribute to CB1 binding in those sectors, but not in
sensorimotor sectors.
Regarding the contribution of CB1 receptors on projection
neurons vs. interneurons, colocalization studies demonstrate that
CB1 receptors are very highly expressed in striatal projection neu-
rons (Marsicano and Lutz, 1999;Hohmann andHerkenham,2000;
Martín et al., 2008). CB1 receptor expression is also established in
(some) fast-spiking, parvalbumin-containing interneurons (Mar-
sicano and Lutz, 1999; Hohmann and Herkenham, 2000; Martín
et al., 2008) and may be present in a minority of NOS-containing
and cholinergic interneurons (Fusco et al., 2004; Uchigashima
et al., 2007). However, given that striatal interneurons in total
only comprise a small fraction (∼3%, Oorschot, 2010) of striatal
neurons, the regional patterns of CB1 mRNA as depicted by ﬁlm
autoradiography (our studies) predominantly reﬂect expression
in striatal projection neurons.
Where on projection neurons are theseCB1 receptors localized?
A prominent feature of striatal projection neurons is their exten-
sive local axon collaterals that distribute roughly in a tissue volume
similar to, and partly overlapping with, that of their dendrites
(Gerfen and Bolam, 2010). These axon collaterals connect to
interneurons and other projection neurons (Figure 6) and form
numerous inhibitory (GABA) synapses onto spines and dendritic
FIGURE 6 | Proposed differential CB1 regulation of collateral (GABA)
inputs and cortical (glutamate, Glu) inputs to striatal projection
neurons in associative/limbic vs. sensorimotor corticostriatal circuits.
The proposed number of CB1 receptors on afferent terminals (see text) is
indicated by the size of squares. Our present ﬁndings indicate an inverse
relationship between cortical and striatal CB1 expression in
associative/limbic circuits with inputs from medial prefrontal cortex
(mPFCx) (left) and sensorimotor circuits (right), with relatively high cortical
and low striatal CB1 expression in the former and low cortical and high
striatal expression in the latter. It is argued that, in sensorimotor
corticostriatal circuits, striatal CB1 receptors are mainly located
presynaptically on local axon collateral terminals of projection neurons
(open triangles) and regulate GABA release from these terminals (see text).
On the other hand, striatal CB1 receptors in associative/limbic circuits may
mostly regulate excitatory inputs from the cortex (ﬁlled triangles) and other
areas (and GABA inputs from interneurons; not shown). The degree of
shading in striatal areas and respective neurons reﬂects the amount of CB1
receptor expression in these neurons. The black dots symbolize
endocannabinoid release from striatal neurons. SMCx, sensorimotor cortex.
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shafts of these neurons (Kubota and Kawaguchi, 2000; Wilson,
2007). Studies show that CB1 receptors are preferentially localized
on axon terminals as opposed to postsynaptic elements (“polar-
ized” distribution; Irving et al., 2000; McDonald et al., 2007).
While some CB1 receptors have been found in dendritic proﬁles
of striatal neurons (e.g., Rodriguez et al., 2001), this polarized dis-
tribution (Irving et al., 2000; McDonald et al., 2007) thus predicts
much higher CB1 receptor levels on axon terminals of these neu-
rons (Herkenham et al., 1991a). The importance of CB1 receptors
on striatal axon collaterals has been demonstrated by electrophys-
iological ﬁndings. For example, stimulation of cannabinoid recep-
tors inhibits GABAergic synaptic transmission between paired
striatal projection neurons (Figure 6), and this effect is mediated
by presynaptic CB1 receptors on axon terminals (Freiman et al.,
2006).
Taken together, the above ﬁndings suggest that CB1 receptor
binding in striatal sectors with high CB1 mRNA levels (sensori-
motor sectors) largely reﬂects presynaptic CB1 receptors on local
collateral terminals of projection neurons that regulate interac-
tions between such neurons (Freiman et al., 2006; Figure 6). On
the other hand,CB1 receptors in striatal areaswith lowCB1mRNA
levels (associative/limbic sectors, nucleus accumbens; e.g., Hoff-
man and Lupica, 2001; Manzoni and Bockaert, 2001) may mostly
regulate GABA inputs from interneurons (e.g., Freiman et al.,
2006), in addition to glutamate inputs from associative/limbic
cortex and other brain regions.
LIMITATIONS
The above hypothesis will need to be tested experimentally. This
hypothesis is based on measurement of mRNA, which is better
quantiﬁable than receptor immunohistochemistry and thus better
suited for mapping studies. Moreover, mRNA “imaging” allows
identiﬁcation of the neurons (cell bodies) that express the recep-
tor. In contrast, receptor binding signals can not differentiate
between receptors on afferent terminals and those on postsynaptic
neurons. Such a differentiation is necessary for the above consid-
erations. However, the main caveat of the mRNA approach is that
mRNA levels not always correlate with receptor levels and func-
tion. As stated above,while we have demonstrated parallel changes
in CB1 mRNA levels and function for cortical neurons, a similar
relationship in striatal neurons remains to be demonstrated.
CONCLUSION: DIFFERENTIAL CB1 SIGNALING IN DIFFERENT
CORTICOSTRIATAL CIRCUITS
Our anatomical comparison of CB1 expression in cortex and
striatum indicates an inverse relationship between cortical and
striatal nodes of sensorimotor corticostriatal circuits and associa-
tive/limbic circuits receiving inputs from medial prefrontal cortex,
with low cortical and high striatal expression and vice versa,
respectively. These ﬁndings indicate that CB1 receptors differ-
entially regulate corticostriatal transmission for these groups of
circuits. Moreover, based on the above considerations, it can be
hypothesized that, in sensorimotor corticostriatal circuits, expo-
sure to cannabinoid drugs will predominantly affect striatal GABA
release from local axon collaterals, whereas in associative/limbic
circuits, cortical glutamate inputs are expected to bemore affected.
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